Human GPC4 ELISA Kit (V2LY-0626-LY3594)

Saroja, S. R., Gorbachev, K., TCW, J., Goate, A. M., & Pereira, A. C. (2022). Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation. Proceedings of the National Academy of Sciences, 119(34), e2108870119.

Muendlein, A., Brandtner, E. M., Leiherer, A., Geiger, K., Heinzle, C., Gaenger, S., ... & Drexel, H. (2022). Evaluation of the association of serum glypican-4 with prevalent and future kidney function. Scientific Reports, 12(1), 1-8.

Muendlein, A., Brandtner, E. M., Leiherer, A., Geiger, K., Heinzle, C., Gaenger, S., ... & Drexel, H. (2022). Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography. Data in Brief, 42, 108142.

Muendlein, A., Brandtner, E. M., Leiherer, A., Geiger, K., Heinzle, C., Gaenger, S., ... & Drexel, H. (2022). Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients. Atherosclerosis, 345, 33-38.

Hu, B., Rodriguez, J. J., Kakkerla Balaraju, A., Gao, Y., Nguyen, N. T., Steen, H., ... & Lin, F. (2021). Glypican 4 mediates Wnt transport between germ layers via signaling filopodia. Journal of Cell Biology, 220(12), e202009082.

Ma, K., Xing, S., Luan, Y., Zhang, C., Liu, Y., Fei, Y., ... & Chen, X. (2021). Glypican 4 regulates Aβ internalization in neural stem cells partly via low-density lipoprotein receptor-related protein 1. Frontiers in Cellular Neuroscience, 15, 732429.

Munir, J., Van Ngu, T., Ayudthaya, P. D. N., & Ryu, S. (2020). Downregulation of glypican-4 facilitates breast cancer progression by inducing cell migration and proliferation. Biochemical and Biophysical Research Communications, 526(1), 91-97.

Hu, B., Gao, Y., Davies, L., Woo, S., Topczewski, J., Jessen, J. R., & Lin, F. (2018). Glypican 4 and Mmp14 interact in regulating the migration of anterior endodermal cells by limiting extracellular matrix deposition. Development, 145(17), dev163303.

Dowling, C., & Allen, N. J. (2018). Mice lacking glypican 4 display juvenile hyperactivity and adult social interaction deficits. Brain Plasticity, 4(2), 197-209.

Cao, J., Ma, J., Sun, L., Li, J., Qin, T., Zhou, C., ... & Han, L. (2018). Targeting glypican‐4 overcomes 5‐FU resistance and attenuates stem cell–like properties via suppression of Wnt/β‐catenin pathway in pancreatic cancer cells. Journal of cellular biochemistry, 119(11), 9498-9512.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols